Orgenesis Inc.
Records under this name other than the patents Orgenesis Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 3 patents it holds.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,808,690 | Methods of Treating Infections Originating from Viruses in the Herpesviridae Family Formerly held In force · High confidence | In force | High confidence | |
| US 8,518,399 | Methods of Treating Infections Originating from Viruses in the Herpesviridae Family Formerly held In force (reinstated) · High confidence | In force (reinstated) | High confidence | |
| US 8,663,964 | Methods of Treating Human Papillomavirus Formerly held In force · High confidence | In force | High confidence | |
| US 9,919,034 | Methods of Treating and Prophylactically Protecting Mammalian Patients Infected by Viruses Classified in Baltimore Group V Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 10,293,032 | Methods and Pharmaceuticals for Treatment of Viral Infections of the Eye Formerly held In force · High confidence | In force | High confidence | |
| US 11,331,378 | Prophylactic Protection Against Viral Infections Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 9,642,794 | Antiviral Pharmaceutical for Topical Administration Formerly held Lapsed on the fee record Ended May 9, 2025 · Medium confidence | Lapsed on the fee record | Ended May 9, 2025 | Medium confidence |
| US 10,975,354 | Transdifferentiated cell populations and methods of use thereof Lapsed on the fee record Ended Apr 13, 2025 · From the USPTO record | Lapsed on the fee record | Ended Apr 13, 2025 | From the USPTO record |
| US 10,947,509 | Cell populations, methods of transdifferentiation and methods of use thereof Lapsed on the fee record Ended Mar 16, 2025 · From the USPTO record | Lapsed on the fee record | Ended Mar 16, 2025 | From the USPTO record |
| US 10,835,598 | Prophylactic Protection Against Viral Infections, Particularly HIV Lapsed on the fee record Ended Nov 17, 2024 · Medium confidence | Lapsed on the fee record | Ended Nov 17, 2024 | Medium confidence |